<P>&nbsp;题号：1</P>
<P>题目：A parallel phase I/II clinical trial design for combination therapies</P>
<P>作者：Huang X, Biswas S, Oki Y, Issa JP, Berry DA.<BR>杂志信息：Biometrics. 2007 Jun;63(2):429-36.<BR>全文链接：<A href="http://www.ncbi.nlm.nih.gov/pubmed/17688495">http://www.ncbi.nlm.nih.gov/pubmed/17688495</A><BR></P>
<P>题号：2</P>
<P>题目：Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios</P>
<P>作者：Yin G, Li Y, Ji Y.<BR>杂志信息：Biometrics. 2006 Sep;62(3):777-84. </P>
<P>全文链接：<A href="http://www.ncbi.nlm.nih.gov/pubmed/16984320">http://www.ncbi.nlm.nih.gov/pubmed/16984320</A></P>
<P>题号：3</P>
<P>题目：The continual reassessment method and its applications: a Bayesian methodology for phase I cancer clinical trials</P>
<P>作者：Ishizuka N, Ohashi Y.</P>
<P>杂志信息：Stat Med. 2001 Sep 15-30;20(17-18):2661-81. <BR><A href="http://www.ncbi.nlm.nih.gov/pubmed/11523075">http://www.ncbi.nlm.nih.gov/pubmed/11523075</A></P>
<P>题号：4</P>
<P>题目：Practical model-based dose-finding in phase I clinical trials: methods based on toxicity.</P>
<P>作者：Thall PF, Lee SJ.</P>
<P>杂志信息：Int J Gynecol Cancer. 2003 May-Jun;13(3):251-61.</P>
<P>全文链接：<A href="http://www.ncbi.nlm.nih.gov/pubmed/12801254">http://www.ncbi.nlm.nih.gov/pubmed/12801254</A></P>
<P>题号：5</P>
<P>题目：Recent Developments in Adaptive Designs for Phase I/II Dose-Finding Studies <BR>作者: Sarah Zohar a; Sylvie Chevret a <BR>杂志信息:&nbsp; Journal of Biopharmaceutical Statistics, Volume 17, Issue 6 November 2007 , pages 1071 - 1083 </P>
<P>全文链接：<A href="http://www.ncbi.nlm.nih.gov/pubmed/18027217">http://www.ncbi.nlm.nih.gov/pubmed/18027217</A></P>
<P>求助者email:rjl.503@hotmail.com</P>
<P align=right><FONT color=#000066>[此贴子已经被作者于2008-7-16 18:54:54编辑过]</FONT></P>